Global Predictive Biomarkers Market
Published Date:Jun 2025
Industry: Healthcare
Regions:
North America,
Europe,
Asia-Pacific,
Latin America,
Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Global Allergy Diagnostics Market Segmentation, By Product & Service (Consumables,
Instruments, Services), By Test Type (In Vivo Tests, {Skin Prick Test (SPT), Intradermal
Test, Patch Test}, In Vitro Tests, {Allergen-specific IgE Test, Total IgE Test,
Component-resolved diagnostics (CRD), Basophil Activation Test (BAT))}, By Allergen
Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), ))},
By End User (Diagnostic Laboratories, Hospital-Based Laboratories and Clinics, Academic
and Research Institutions, Other End Users)- Industry Trends and Forecast
to 2033
The Global
Allergy Diagnostics Market size was valued at USD 5367.6
million in 2024 and is expected to grow at a CAGR of 10.8% during the
forecast period of 2025 to 2033.
Global Allergy Diagnostics Market Overview:
The Global Allergy
Diagnostics Market prevalence of allergic conditions such as asthma, allergic
rhinitis, and food allergies creates substantial growth. Market expansion is
driven by three main factors, which include rising environmental pollution,
lifestyle changes, and greater awareness of allergy-related health issues.
Healthcare professionals use multiple diagnostic methods, including skin prick
tests, specific IgE blood tests, and patch tests, to determine the exact
allergens causing reactions. The combination of technological progress and
better diagnostic precision, along with the increasing need for individualized
allergy management, encourages wider use in medical and research applications.
The global market growth benefits from rising healthcare spending alongside
improved access to diagnostic services.
Global Allergy Diagnostics Market Scope:
|
Factors |
Description |
|
Years Considered |
Historical Period: 2020-2023 Base Year: 2024 Forecast Period: 2025-2033 |
|
Segments |
By Product & Service: (Consumables, Instruments, Services) By Test Type: (In Vivo Tests, {Skin Prick Test (SPT), Intradermal
Test, Patch Test}, In Vitro Tests, {Allergen-specific IgE Test, Total IgE
Test, Component-resolved diagnostics (CRD), Basophil Activation Test (BAT))},
By Allergen Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other
Allergens)))} By End User: (Diagnostic Laboratories, Hospital-Based Laboratories
and Clinics, Academic and Research Institutions, Other End Users) |
|
Countries Catered |
· North America · United States · Canada · Mexico · Europe · United Kingdom · Germany · France · Spain · Italy · Rest of Europe Asia Pacific · China · India · Japan · Australia · South Korea · Rest of Asia Pacific · Latin America · Brazil · Argentina · Rest of Latin America · Middle East & Africa · Saudi Arabia · South Africa · Rest of MEA |
|
Key Companies |
· Thermo Fisher
Scientific, Inc. |
|
Market Trends |
· Increasing demand for IVD tests for allergy diagnosis · Growing healthcare expenditure of effective allergy diagnostic
& therapeutic products. |
Global Allergy
Diagnostics Market Dynamics
The market for
Global Needle-free Injectors is witnessing high rate of technological change
due to increasing demand for efficient and painless drug delivery devices that
are easily administered by the patients. Increasing prevalence of chronic
diseases such as diabetes and osteoporosis has resulted in the need for
self-administrable devices and less invasive administration methods. These
injectors have substantial benefits such as low incidence of needle-stick
injuries, improved patient compliance and rapid absorption of drugs. Rapid jet
injectors in combination with spring-based systems have enhanced the precision
and control in drug delivery systems. Wide acceptance of these devices in
immunization programs and their pediatric uses will drive their demand
globally. Higher prices and lack of awareness in developing regions are major
restraints in these regions. Despite the challenges, R&D activities,
regulatory approvals and healthcare investments will drive the growth of the
market in both developed and developing economies.
Global Allergy
Diagnostics Market Segment Analysis
The Global
Allergy Diagnostics Market divides into multiple categories according to
product & service types, test methods, allergen classifications, and end
user applications, which demonstrate the market’s diverse diagnostic needs and
applications. The market segmentation by Product & Service divides into
consumables, instruments, and services. Allergen extracts, assay kits, and
reagents represent the primary products in this segment because of their
frequent application in repeated testing procedures. Immunoassay analysers and
luminometers are essential tools for performing in vitro tests because they
deliver precise results and high processing capacity. Diagnostic centres and
labs have expanded their service range, which now encompasses test results analysis
and interpretation along with consultation services. Test Type creates market
divisions between in vivo tests and in vitro tests. The Skin Prick Test (SPT),
Intradermal Test, and Patch Test qualify as in vivo tests that healthcare
facilities use because they provide quick results and remain cost-effective.
The increasing popularity of in vitro tests stems from their dependable
performance and safe nature since they eliminate direct allergen exposure while
maintaining operational efficiency. The primary in vitro tests are
allergen-specific IgE test along with total IgE test, component-resolved
diagnostics (CRD) and Basophil Activation Test (BAT) which enables
cellular-level allergic sensitivity assessment.
The global
market divides according to allergen type into inhaled allergens which include
pollen and dust mites as well as food allergens comprising nuts and dairy as
well as seafood and drug allergens such as penicillin besides other allergens
like latex and insect venom. Inhaled allergens represent a major portion of
diagnostic cases for asthma and rhinitis while food allergies show an upward
trend especially among children. Diagnostic laboratories, hospital-based
laboratories and clinics, academic and research institutions along with
wellness centres and other end users make up the market's served customer base.
Diagnostic laboratories achieve the highest volume of tests because of their
ability to process a large number of tests simultaneously and their access to
sophisticated testing technologies. Integrated healthcare delivery systems
provide benefits to hospital-based laboratories, whereas research institutions
push forward innovation via clinical studies and allergy research.
Global Allergy
Diagnostics Market Regional Analysis
Distinct
regional growth patterns in the Global Allergy Diagnostics Market stem from
diverse healthcare systems and varying levels of allergy prevalence and
awareness about diagnostic processes. North America leads the diagnostic market
due to its high allergic disease rates combined with robust healthcare systems
and advanced diagnostic technologies. Germany, France, and the UK drive strong
performance in the European allergy diagnostic market through supportive public
health initiatives and reimbursement policies. The Asia-Pacific region
experiences rapid growth as higher pollution levels join increased urbanization
to boost allergy disorder awareness in China, India, and Japan. Healthcare
infrastructure investments, together with rising personal incomes, improve
access to diagnostic services. Healthcare advancements coupled with growing
awareness are leading to more allergy testing requests throughout Latin America
and the Middle East & and Africa. Areas lacking diagnostic facilities and
affordable services encounter immediate market entry obstacles.
Global Allergy Diagnostics Market Key
Players
·
Thermo Fisher Scientific, Inc.
·
HYCOR Biomedical
·
EUROIMMUN Medizinische
Labordiagnostika AG
·
Omega Diagnostics Group PLC
·
Lincoln Diagnostics, Inc.
·
AESKU GROUP GmbH
·
DASIT Group SPA
·
R-Biopharm AG
·
bioMérieux
·
Siemens Healthcare GmbH
Recent Developments:
In July 2024, AliveDx
received IVDR CE‑mark approval for
its novel microarray immunoassay designed to detect specific IgE responses to
protein allergens, boosting diagnostic precision in allergy component testing
In July 2024, Roche
acquired microfluidic diagnostics specialist LumiraDx to strengthen its
point-of-care testing capabilities, enhancing access to rapid allergy
diagnostics in primary care settings.
Research Methodology
At Foreclaro
Global Research, our research methodology is firmly rooted in a comprehensive
and systematic approach to market research. We leverage a blend of reliable
public and proprietary data sources, including industry reports, government
publications, company filings, trade journals, investor presentations, and
credible online databases. Our analysts critically evaluate and triangulate
information to ensure accuracy, consistency, and depth of insights. We follow a
top-down and bottom-up data modelling framework to estimate market sizes and
forecasts, supplemented by competitive benchmarking and trend analysis. Each
research output is tailored to client needs, backed by transparent data
validation practices, and continuously refined to reflect dynamic market
conditions.
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Regulatory Scenario
1.4. Executive Summary
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Secondary Analyst Tools and Models
Chapter 3. Market Dynamics
3.1. Market
driver analysis
3.1.1. Rising
adoption of personalized and precision medicine
3.1.2. Increasing
prevalence of chronic diseases and cancer
3.2. Market
restraint analysis
3.2.1. High
cost of biomarker validation and development
3.3. Market
Opportunity
3.3.1. Expanding
application in immunotherapy and targeted therapy
3.4. Market
Challenges
3.4.1. Lack
of standardized biomarker validation frameworks
Chapter 4. Market Variables and
Outlook
4.1. SWOT
Analysis
4.1.1. Strengths
4.1.2. Weaknesses
4.1.3. Opportunities
4.1.4. Threats
4.2. PESTEL
Analysis
4.2.1. Political
Landscape
4.2.2. Economic Landscape
4.2.3. Social
Landscape
4.2.4. Technological
Landscape
4.2.5. Environmental
Landscape
4.2.6. Legal
Landscape
4.3. Porter’s
Five Forces Analysis
4.3.1. Bargaining
Power of Suppliers
4.3.2. Bargaining
Power of Buyers
4.3.3. Threat
of Substitute
4.3.4. Threat
of New Entrant
4.3.5. Competitive
Rivalry
4.4. Value
Chain Analysis
4.5. Covid
Impact Analysis
Chapter 5. Predictive Biomarkers
Market: Biomarkers Type Estimates & Trend Analysis
5.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
5.2. Incremental
Growth Analysis and Infographic Presentation
5.3. Genetic
Biomarkers
5.4. Protein
Biomarkers
5.5. Metabolic
Biomarkers
5.6. Epigenetic
Biomarkers
5.7. Transcriptomic
Biomarkers
5.8. Lipid
Biomarkers
5.9. Immune
Biomarkers
Chapter 6. Predictive Biomarkers
Market: Application Estimates & Trend Analysis
6.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
6.2. Incremental
Growth Analysis and Infographic Presentation
6.3. Oncology
6.4. Cardiology
6.5. Neurology
6.6. Infectious
Diseases
6.7. Autoimmune
Disorders
6.8. Endocrinology
6.9. Gastroenterology
Chapter 7. Predictive Biomarkers
Market: Technology Estimates & Trend Analysis
7.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
7.2. Incremental
Growth Analysis and Infographic Presentation
7.3. Polymerase
Chain Reaction (PCR)
7.4. Next-Generation
Sequencing (NGS)
7.5. Immunoassays
7.6. Mass
Spectrometry
7.7. Microarray
Technology
7.8. Bioinformatics
and Artificial Intelligence
Chapter 8. Predictive Biomarkers
Market: End Users Estimates & Trend Analysis
8.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
8.2. Incremental
Growth Analysis and Infographic Presentation
8.3. Pharmaceutical
& Biotechnology Companies
8.4. Diagnostic
Laboratories
8.5. Academic
& Research Institutions
8.6. Hospitals
& Clinics
8.7. Contract
Research Organizations (CROs)
Chapter 9. Predictive Biomarkers
Market: Regional Estimates & Trend Analysis
9.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
9.2. Incremental
Growth Analysis and Infographic Presentation
9.3. North
America
9.4. Europe
9.5. Asia
Pacific
9.6. Middle
East & Africa
9.7. Latin
America
Chapter 10. Predictive Biomarkers
Market: Country Estimates & Trend Analysis
10.1. Predictive
Biomarkers Market value share and forecast, (2020 to 2033)
10.2. Incremental
Growth Analysis and Infographic Presentation
10.3. United
States
10.4. Canada
10.5. Mexico
10.6. United
Kingdom
10.7. France
10.8. Germany
10.9. Italy
10.10. Spain
10.11. China
10.12. India
10.13. Japan
10.14. South
Korea
10.15. Australia
10.16. Brazil
10.17. Argentina
10.18. Saudi
Arabia
10.19. South
Africa
Chapter 11. Competitive Landscape
11.1. Company
Market Share Analysis
11.2. Vendor
Landscape
11.3. Competition
Dashboard
Chapter 12. Company Profiles
12.1. Thermo
Fisher Scientific
12.1.1. Company
Overview
12.1.2. Financial
Details
12.1.3. Product
Analysis
12.1.4. Recent
Developments
12.2. F.
Hoffmann‑La
Roche (Roche)
12.2.1. Company
Overview
12.2.2. Financial
Details
12.2.3. Product
Analysis
12.2.4. Recent
Developments
12.3. Qiagen
12.3.1. Company
Overview
12.3.2. Financial
Details
12.3.3. Product
Analysis
12.3.4. Recent
Developments
12.4. Illumina
12.4.1. Company
Overview
12.4.2. Financial
Details
12.4.3. Product
Analysis
12.4.4. Recent
Developments
12.5. Bio‑Rad
Laboratories
12.5.1. Company
Overview
12.5.2. Financial
Details
12.5.3. Product
Analysis
12.5.4. Recent
Developments
12.6. Danaher
Corporation
12.6.1. Company
Overview
12.6.2. Financial
Details
12.6.3. Product
Analysis
12.6.4. Recent
Developments
12.7. Siemens
Healthineers
12.7.1. Company
Overview
12.7.2. Financial
Details
12.7.3. Product
Analysis
12.7.4. Recent
Developments
12.8. Myriad
Genetics
12.8.1. Company
Overview
12.8.2. Financial
Details
12.8.3. Product
Analysis
12.8.4. Recent
Developments
12.9. PerkinElmer
12.9.1. Company
Overview
12.9.2. Financial
Details
12.9.3. Product
Analysis
12.9.4. Recent
Developments
12.10. Becton
Dickinson (BD)
12.10.1.
Company Overview
12.10.2.
Financial Details
12.10.3.
Product Analysis
12.10.4.
Recent Developments
12.11. Bio‑Techne
12.11.1.
Company Overview
12.11.2.
Financial Details
12.11.3.
Product Analysis
12.11.4.
Recent Developments
12.12. Genomic
Health
12.12.1.
Company Overview
12.12.2.
Financial Details
12.12.3.
Product Analysis
12.12.4.
Recent Developments
12.13. Epigenomics
AG
12.13.1.
Company Overview
12.13.2.
Financial Details
12.13.3.
Product Analysis
12.13.4.
Recent Developments
12.14. Ayoxxa
Biosystems
12.14.1.
Company Overview
12.14.2.
Financial Details
12.14.3.
Product Analysis
12.14.4.
Recent Developments
12.15. Quibim
12.15.1.
Company Overview
12.15.2.
Financial Details
12.15.3.
Product Analysis
12.15.4. Recent Developments
Segmentation
1. By Biomarker Type:
- Genetic Biomarkers
Protein Biomarkers
Metabolic Biomarkers
Epigenetic Biomarkers
Transcriptomic Biomarkers
Lipid Biomarkers
Immune Biomarkers
2. By Application:
Oncology
Cardiology
Neurology
Infectious Diseases
Autoimmune Disorders
Endocrinology
Gastroenterology
3. By Technology:
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Immunoassays
Mass Spectrometry
Microarray Technology
Bioinformatics and Artificial Intelligence
4. By End User:
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Academic & Research Institutions
Hospitals & Clinics
Contract Research Organizations (CROs)
Methodology
Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.
At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.
1. Defining the Research Framework
Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.
2. Robust Data Collection
Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.
3. Advanced Forecasting and Modeling
To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.
4. Data Triangulation and Validation
Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.
5. Quality Assurance and Final Review
Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.
Why Our Methodology Works
What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.
Related Reports
-
Healthcare Forecast: 2026-2033
Menopause Market Outlook, Growth & CAGR
Global Menopause Market Segmentation, By Treatment Type (Hormone Replacement Therapy (HRT), Non-Hormonal Therapy, Dietary Supplements & Nutraceuti...
-
Healthcare Forecast: 2026-2033
Occupational Rehabilitation Market Report Forecast
Global Occupational Rehabilitation Market Segmentation, By Service Type (Physical Therapy, Occupational Therapy, Vocational Rehabilitation, Ergonomic...
-
Healthcare Forecast: 2026-2033
Global Hospital-at-Home (HaH) Technology Market
Global Hospital-at-Home (HaH) Technology Market Segmentation, By Technology Type (Remote Patient Monitoring Systems, Telehealth & Virtual Care Pla...
-
Healthcare Forecast: 2026-2033
Global Clinical Intelligence Market
Global Clinical Intelligence Market Segmentation, By Application (Clinical Decision Support, Patient Management, Data Analytics, Workflow Optimizati...